← Back to Clinical Trials
Recruiting NCT06266416

IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Sexually Transmitted Infections (Not HIV or Hepatitis)
Sponsor University of Illinois at Chicago
Study Type INTERVENTIONAL
Phase N/A
Enrollment 612
Sex ALL
Min Age 14 Years
Max Age N/A
Start Date 2024-10-05
Completion 2027-05-31
Interventions
IMARA for Black Male Caregivers and Girls EmpowermentTime-matched control program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The scientific premise of this research is that individual, interpersonal, and structural factors impact Black girls' sexual reproductive health outcomes (sexually transmitted infection (STI) and Human Immunodeficiency Virus (HIV)) and experience of sexual violence. This study expands STI/HIV prevention programs to include Black male caregivers, a potentially valuable yet underutilized resource to protect Black girls and reduce their exposure to STI/HIV and sexual violence.

Eligibility Criteria

Inclusion Criteria: AIM 1: * Self-identify as African American, Black, or mixed race with African American or Black * Speak English * Males must identify as a current caregiver to girl enrolled in the study AIM 2: All Community Based Organizations (CBO) directors and IMAGE liaisons will be eligible. Exclusion Criteria: AIM 1: * Girl refuses to participate * Inability to understand the consent/assent process * Non-English speaking * Does not self-identify as African American, Black, or mixed race with African American or Black * If the primary caregiver (female caregiver/mother) does not consent to the girls' participation with the male caregiver the girl chooses, the girl will not be able to participate * Girls will be excluded if they participated in other phases of the research AIM 2: • Inability to understand the consent process, and non-employment at a partnering CBO.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}